Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$229M |
| 2 |
Microsoft
MSFT
|
+$191M |
| 3 |
Meta Platforms (Facebook)
META
|
+$178M |
| 4 |
PepsiCo
PEP
|
+$156M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$144M |
Top Sells
| 1 |
BCR
CR Bard Inc.
BCR
|
+$243M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$163M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$85.5M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$75.9M |
| 5 |
SFR
Starwood Waypoint Homes
SFR
|
+$45.3M |
Sector Composition
| 1 | Technology | 16.88% |
| 2 | Financials | 16.38% |
| 3 | Healthcare | 13.22% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2376
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $3.61M | ﹤0.01% |
606,510
+3,416
| +0.6% | +$20.3K |
|
2377
Rhythm Pharmaceuticals
RYTM
$6.66B
| $3.6M | ﹤0.01% |
+123,795
| New | +$3.6M |
|
|
AFI
2378
DELISTED
Armstrong Flooring, Inc.
AFI
| $3.6M | ﹤0.01% |
212,569
-6,573
| -3% | -$111K |
|
|
PRTK
2379
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.59M | ﹤0.01% |
200,782
+5,151
| +3% | +$92.2K |
|
2380
First Community Bankshares
FCBC
$684M
| $3.58M | ﹤0.01% |
124,736
+644
| +0.5% | +$18.5K |
|
2381
Mesa Laboratories
MLAB
$327M
| $3.56M | ﹤0.01% |
28,679
+77
| +0.3% | +$9.57K |
|
2382
Atara Biotherapeutics
ATRA
$82.7M
| $3.56M | ﹤0.01% |
7,874
+190
| +2% | +$86K |
|
|
BRS
2383
DELISTED
Bristow Group, Inc.
BRS
| $3.56M | ﹤0.01% |
264,583
+11,179
| +4% | +$150K |
|
2384
NovoCure
NVCR
$1.37B
| $3.56M | ﹤0.01% |
176,000
+3,823
| +2% | +$77.2K |
|
|
AKCA
2385
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $3.55M | ﹤0.01% |
204,540
+3,147
| +2% | +$54.6K |
|
2386
Collegium Pharmaceutical
COLL
$1.19B
| $3.54M | ﹤0.01% |
191,634
+14,589
| +8% | +$269K |
|
|
GLUU
2387
DELISTED
Glu Mobile Inc.
GLUU
| $3.54M | ﹤0.01% |
971,926
+22,206
| +2% | +$80.8K |
|
2388
Shoe Carnival
SCVL
$653M
| $3.54M | ﹤0.01% |
264,450
-139,460
| -35% | -$1.86M |
|
|
DNI
2389
DELISTED
Dividend and Income Fund
DNI
| $3.52M | ﹤0.01% |
262,237
+29,071
| +12% | +$390K |
|
2390
Nicolet Bankshares
NIC
$2B
| $3.51M | ﹤0.01% |
64,095
+4,540
| +8% | +$248K |
|
|
BFX
2391
DELISTED
BowFlex Inc.
BFX
| $3.5M | ﹤0.01% |
262,546
+2,411
| +0.9% | +$32.2K |
|
|
ANCX
2392
DELISTED
Access National Corporation
ANCX
| $3.5M | ﹤0.01% |
125,888
+824
| +0.7% | +$22.9K |
|
|
ASNA
2393
DELISTED
Ascena Retail Group, Inc.
ASNA
| $3.5M | ﹤0.01% |
74,473
+1,894
| +3% | +$89K |
|
2394
Cytokinetics
CYTK
$6.22B
| $3.49M | ﹤0.01% |
428,548
+6,813
| +2% | +$55.5K |
|
2395
Cato Corp
CATO
$89.6M
| $3.49M | ﹤0.01% |
219,077
-12,482
| -5% | -$199K |
|
2396
Spok Holdings
SPOK
$356M
| $3.49M | ﹤0.01% |
222,906
-41,854
| -16% | -$655K |
|
2397
Synchronoss Technologies
SNCR
$62.8M
| $3.49M | ﹤0.01% |
43,325
+1,400
| +3% | +$113K |
|
2398
Zumiez
ZUMZ
$356M
| $3.48M | ﹤0.01% |
167,142
+4,885
| +3% | +$102K |
|
2399
Digimarc
DMRC
$203M
| $3.47M | ﹤0.01% |
96,022
+1,538
| +2% | +$55.6K |
|
2400
Park-Ohio Holdings
PKOH
$310M
| $3.47M | ﹤0.01% |
75,410
+677
| +0.9% | +$31.1K |
|